Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M71,419Revenue $M10,299Net Margin (%)33.9Altman Z-Score12.6
Enterprise Value $M69,630EPS $14.8Operating Margin %45.1Piotroski F-Score9
P/E(ttm)20.5Beneish M-Score-2.2Pre-tax Margin (%)44.8Higher ROA y-yY
Price/Book5.710-y EBITDA Growth Rate %26.5Quick Ratio1.9Cash flow > EarningsY
Price/Sales7.05-y EBITDA Growth Rate %25.5Current Ratio2.2Lower Leverage y-yY
Price/Free Cash Flow22.2y-y EBITDA Growth Rate %44.7ROA % (ttm)23.9Higher Current Ratio y-yY
Dividend Yield %--PEG0.8ROE % (ttm)31.7Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M235ROIC % (ttm)36.6Gross Margin Increase y-yY

Gurus Latest Trades with BIIB

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BIIBVanguard Health Care Fund 2015-06-30 Add1.17%$373.93 - $430.96
($401.66)
$ 303.69-24%Add 425.02%1,780,330
BIIBMario Gabelli 2015-06-30 Reduce$373.93 - $430.96
($401.66)
$ 303.69-24%Reduce 2.74%4,797
BIIBKen Fisher 2015-06-30 Reduce$373.93 - $430.96
($401.66)
$ 303.69-24%Reduce 0.16%80,932
BIIBVanguard Health Care Fund 2015-03-31 Buy 0.31%$334.65 - $475.98
($394.14)
$ 303.69-23%New holding339,100
BIIBJoel Greenblatt 2015-03-31 Sold Out -0.014%$334.65 - $475.98
($394.14)
$ 303.69-23%Sold Out0
BIIBMario Gabelli 2015-03-31 Reduce$334.65 - $475.98
($394.14)
$ 303.69-23%Reduce 0.06%4,932
BIIBKen Fisher 2015-03-31 Add$334.65 - $475.98
($394.14)
$ 303.69-23%Add 2.28%81,058
BIIBKen Heebner 2014-12-31 Sold Out -0.75%$299.1 - $360.67
($323.29)
$ 303.69-6%Sold Out0
BIIBVanguard Health Care Fund 2014-12-31 Sold Out -0.2%$299.1 - $360.67
($323.29)
$ 303.69-6%Sold Out0
BIIBJoel Greenblatt 2014-12-31 Reduce-0.08%$299.1 - $360.67
($323.24)
$ 303.69-6%Reduce 84.03%5,012
BIIBKen Heebner 2014-09-30 Buy 0.75%$299.29 - $346.3
($329.79)
$ 303.69-8%New holding80,000
BIIBVanguard Health Care Fund 2014-09-30 Reduce-0.27%$299.29 - $346.3
($329.79)
$ 303.69-8%Reduce 58.26%233,600
BIIBJoel Greenblatt 2014-09-30 Buy 0.1%$299.29 - $346.3
($329.79)
$ 303.69-8%New holding31,391
BIIBKen Heebner 2014-06-30 Sold Out -0.95%$274 - $320.13
($300.74)
$ 303.691%Sold Out0
BIIBKen Fisher 2014-06-30 Add0.05%$274 - $320.13
($300.74)
$ 303.691%Add 386.61%88,885
BIIBVanguard Health Care Fund 2014-06-30 Reduce-0.03%$274 - $320.13
($301.05)
$ 303.691%Reduce 6.62%559,700
BIIBJoel Greenblatt 2014-06-30 Sold Out -0.02%$274 - $320.13
($300.74)
$ 303.691%Sold Out0
BIIBGeorge Soros 2014-06-30 Sold Out -0.02%$274 - $320.13
($300.74)
$ 303.691%Sold Out0
BIIBRon Baron 2014-06-30 Add$274 - $320.13
($300.74)
$ 303.691%Add 41.76%8,632
BIIBMario Gabelli 2014-06-30 Add$274 - $320.13
($301.05)
$ 303.691%Add 16.46%4,175
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BIIB is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BIIB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
PAPADOPOULOS STELIOSDirector 2015-07-27Buy10,000$304.88-0.39view
Posner Brian SDirector 2015-06-22Sell470$415-26.82view
WILLIAMS DOUGLAS EEVP Research & Development 2015-06-19Sell3,841$410-25.93view
Posner Brian SDirector 2015-06-15Sell400$386.64-21.45view
SCANGOS GEORGE ACEO 2015-06-01Sell1,362$398.87-23.86view
SCANGOS GEORGE ACEO 2015-05-01Sell1,362$377.52-19.56view
SCANGOS GEORGE ACEO 2015-04-01Sell1,362$423.2-28.24view
Sandrock AlfredGrp SVP, Chief Medical Officer 2015-03-27Sell430$430.12-29.39view
Cox JohnEVP Pharmaceutical Oper & Tech 2015-03-25Sell12,010$449.06-32.37view
Rowinsky Eric KDirector 2015-03-20Sell11,667$475-36.07view

Press Releases about BIIB :

Quarterly/Annual Reports about BIIB:

News about BIIB:

Articles On GuruFocus.com
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Biogen Inc. of Pendency of Class A Aug 20 2015 
The Best Companies of the Pharmaceuticals Industry – August 2015 Aug 18 2015 
Vanguard Health Care Fund Buys Two New Stakes in Second Quarter Aug 06 2015 
shortlist Jul 19 2015 
shortlist Jul 19 2015 
shortlist Jul 19 2015 
shortlist Jul 19 2015 
Investment Strategies for the Bullish Biotech Sector Jun 01 2015 
Apple, SunEdison and Biogen: Hellman, Jordan Management's Top 3 Stocks Outperform the Rise in the S& May 28 2015 
PRIMECAP Sells Portions of Its Top Two Stakes May 27 2015 

More From Other Websites
Gilead & Amgen Account for Nearly 75% of the Biotech Profit Pool Aug 28 2015
Biogen And Gilead Sciences Catch The Eye Of Short Sellers Aug 27 2015
'We See Opportunity in Biogen, Gilead and Regeneron,' Morgan Stanley Says Aug 27 2015
Here's who Mass. biotechs are supporting in recent elections (BBJ DataCenter) Aug 26 2015
Biogen Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate... Aug 26 2015
Short Sellers Become More Focused in Major Biotechs Aug 26 2015
AMAG is a Hidden Biotech Gem That is Exploding Aug 25 2015
Biogen (BIIB) Crumbles: Stock Falls by 5.9% Aug 25 2015
Trading the historic market dip: 6 stocks to buy Aug 24 2015
Biogen Pipeline Doesn't Justify High Valuation Aug 24 2015
Biotech blues despite 12% gain YTD Aug 24 2015
Why Medivation is a Stunning Biotech Opportunity Aug 21 2015
4 Reasons To Keep An Eye On Biotech Stock Celgene Aug 21 2015
Using ETFs To Run Your Own Hedge Fund Aug 20 2015
Key Financial Ratios to Analyze Biotech Companies Aug 20 2015
Applied Genetic Solidifies Deal With Biogen Aug 20 2015
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Biogen Inc. of Pendency of Class... Aug 20 2015
AGTC Announces Strategic Collaboration With Biogen Effective and Biogen Equity Investment Closed Aug 20 2015
Celgene May be The Single Best Biotech in the World Aug 19 2015
Top trades: Target, SunEdison, Biogen & more Aug 19 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK